Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MTIF3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | C17orf51 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | ANKRD26 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | SNTA1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | AMFR | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | SGCE | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | GJB2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | PTPN7 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
mRNA | UBQLN2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | DENND5B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |